Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE005416 |
YEM_ID: | YEM-639 |
XU_ID: | XU-540 |
ID: | TCMBANKHE005416/YEM-639/XU-540 |
植物拉丁名: |
|
功能与主治: | Treatment of morbid leukorrhea, diarrhea caused by damp-heat, chronic diarrhea, chronic dysentery, hematochezia, abnormal uterine bleeding, to remove damp-heat and arrest discharges./Treatment of morbid leukorrhea, diarrhea caused by damp-heat, chronic diarrhea, chronic dysentery, hematochezia, abnormal uterine bleeding. |
药用植物名: | 椿根皮,椿皮|臭椿 |
药名: | 臭椿 |
来源: | 云南民族药物志：第四卷|云南省大理州下关 |
药用部位: | Ailanthus altissima (Mill.) Swingle|枝叶 |
使用民族: | 瑶族/彝族 |
药味: | Cool; Bitter; Punkery |
经络: | Large Intestine; Liver |
治疗类型: | 清热燥湿药 |
KUMST_ID1: | KMUST-BS-0553 |
KUMST_ID2: | KMUST-2024041100092-1 |
TCM_ID_id: | 70,302,300 |
SymMap_id: | 81 |
TCMSP_id: | 122 |
Swingle|Ailanthus altissima1.jpg)
Swingle|Ailanthus altissima2.jpg)
Swingle|Ailanthus altissima3.jpg)
Swingle|Ailanthus altissima4.jpg)
Swingle|Ailanthus altissima5.jpg)
Swingle1.jpg)
Swingle2.jpg)
Swingle3.jpg)
Swingle4.jpg)
Swingle5.jpg)
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN003060 | ()-Valencene | 75056_FLUKA; (3R,4aR,5R)-4a,5-dimethyl-3-prop-1-en-2-yl-2,3,4,5,6,7-hexahydro-1H-naphthalene; W344303_ALDRICH; (3R,4aR,5R)-3-isopropenyl-4a,5-dimethyl-2,3,4,5,6,7-hexahydro-1H-naphthalene; (3R,4aS,5R)-4a,5-Dimethyl-3-isopropenyl-1,2,3,4,4a,5,6,7-octahydronaphthalene | C15H24 | 204.35 | CC1CCC=C2C1(CC(CC2)C(=C)C)C |
| TCMBANKIN003552 | ercycibes a | ||||
| TCMBANKIN003765 | Vilmorrianine C | vilmorrianine c | C35H49NO9 | 627.76 | CCN1CC2(CCC(C34C2C(C(C31)C5(CC(C6CC4C5C6OC(=O)C7=CC=C(C=C7)OC)OC)OC(=O)C)OC)OC)COC |
| TCMBANKIN004409 | (3S,6R,8S,9S,10R,13R,14S,17R)-17-[(1R,4S)-4-ethyl-1,5-dimethylhexyl]-10,13-dimethyl-2,3,6,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,6-diol | (3S,6R,8S,9S,10R,13R,14S,17R)-17-[(2R,5S)-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-2,3,6,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,6-diol; (3S,6R,8S,9S,10R,13R,14S,17R)-17-[(2R,5S)-5-ethyl-6-methyl-heptan-2-yl]-10,13-dimethyl-2,3,6,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,6-diol; (3S,6R,8S,9S,10R,13R,14S,17R)-17-[(1R,4S)-4-ethyl-1,5-dimethyl-hexyl]-10,13-dimethyl-2,3,6,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,6-diol | 430.79 | ||
| TCMBANKIN005099 | chaparrione | ||||
| TCMBANKIN005243 | Shinjulactone A | Picrasa-3,13(21)-dien-16-one, 11,20-epoxy-1,2,11,12-tetrahydroxy-, (1.beta.,2.alpha.,11.beta.,12.alpha.); Picrasa-3,13(21)-dien-16-one, 11,20-epoxy-1,2,11,12-tetrahydroxy-, (1beta,2alpha,11beta,12alpha); AIDS026411; 89353-91-3; AIDS-026411 | C20H26O7 | 378.42 | CC1=CC(C(C2(C1CC3C45C2C(C(C(=C)C4CC(=O)O3)O)(OC5)O)C)O)O |
| TCMBANKIN005846 | ()-Ledene | (1S,2R,3R,11R)-3,3,7,11-Tetramethyltricyclo[6.3.0.02.4]undec-7-ene; 61770_FLUKA | C15H24 | 204.35 | |
| TCMBANKIN006208 | Ailantone | C08747; 2H-1,11c-(Epoxymethano)phenanthro(10,1-bc)pyran-5,10(3H,6ah)-dione, 1,3a,4,7,7a,11,11a,11b-octahydro-8,11a-beta-dimethyl-3-methylene-1-alpha,2-beta,11-beta-trihydroxy-; AIDS-026407; Picrasa-3,13(21)-dien-2,16-dione, 11,20-epoxy-1,11,12-trihydroxy-, (1.beta.,11.beta.,12.alpha.); Picrasa-3,13(21)-diene-2,16-dione, 11,20-epoxy-1,11,12-trihydroxy-, (1beta,11beta,12alpha)-; 981-15-7; Ailanthone; AIDS026407; Ailanthone (7CI); Picrasa-3,13(21)-diene-2,16-dione, 11,20-epoxy-1,11,12-trihydroxy-, (1-beta,11-beta,12-alpha)- | C20H24O7 | 376.4 | CC1=CC(=O)C(C2(C1CC3C45C2C(C(C(=C)C4CC(=O)O3)O)(OC5)O)C)O |
| TCMBANKIN006575 | Epi-bicyclosesauiphellandrene | (+)-Epi-bicyclosesqulphellandrene | C15H24 | 204.35 | |
| TCMBANKIN006905 | alpha-amorphene | α-amorphene | C15H24 | 204.35 | |
| TCMBANKIN006930 | β-guaiene | beta-guaiene; (+)-β-Guaiene | C15H24 | 204.35 | CC1CCC(=C(C)C)CC2=C1CCC2C |
| TCMBANKIN007162 | ocotillol | ocotillone | C30H52O3 | 460.73 | CC1(C2CCC3(C(C2(CCC1O)C)CCC4C3(CCC4C5(CCC(O5)C(C)(C)O)C)C)C)C |
| TCMBANKIN007703 | 7-methoxy-2H-chromene | ghl.PD_Mitscher_leg0.899 | C10H10O2 | 162.19 | COC1=CC2=C(C=CCO2)C=C1 |
| TCMBANKIN007977 | Amarolide | AIDS-026413; Picrasane-1,12,16-trione, 2,11-dihydroxy-, (2.alpha.,11.alpha.)-; (2alpha,11alpha)-2,11-Dihydroxypicrasane-1,12,16-trione; 29913-86-8; amarolide; AIDS026413; Picrasane-1,12,16-trione, 2,11-dihydroxy-, (2alpha,11alpha)-; (2.alpha.,11.alpha.)-2,11-Dihydroxypicrasane-1,12,16-trione | C20H28O6 | 364.43 | CC1CC(C(=O)C2(C1CC3C4(C2C(C(=O)C(C4CC(=O)O3)C)O)C)C)O |
| TCMBANKIN014135 | ailantinol A | C21H26O8 | 406.43 | CC1=CC(=O)C(C2(C1CC3C4(C2C(=O)OC4)C(CC(=O)O3)C(C)C(=O)OC)C)O | |
| TCMBANKIN014159 | mersosin | CCC(C)C(C(=O)NCC(=O)NC(CO)C(=O)NC(CCCN=C(N)N)C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N | |||
| TCMBANKIN014611 | Thapsic acid | LMFA01170022; 52230_FLUKA; 1,16-Hexadecanedioic acid; NSC15164; Hexadecane-1,16-dioic acid; 1,14-Tetradecanedicarboxylic acid; 177504_ALDRICH; AIDS002608; EINECS 208-013-5; 505-54-4; n-Tetradecane-omega,omega'-dicarboxylic acid; Hexadecanedioic acid; MEGxp0_000578; n-Tetradecane-.omega.,.omega.'-dicarboxylic acid; NSC 15164; AIDS-002608 | C16H30O4 | 286.41 | C(CCCCCCCC(=O)O)CCCCCCC(=O)O |
| TCMBANKIN015379 | 1-Acetyl-beta-carboline | 1-(9H-beta-carbolin-1-yl)ethanone; 1-acetyl-β-carboline; InChI=1/C13H10N2O/c1-8(16)12-13-10(6-7-14-12)9-4-2-3-5-11(9)15-13/h2-7,15H,1H; 1-(9H-$b-carbolin-1-yl)ethanone; 1-(9H-pyrido[3,4-b]indol-1-yl)ethanone; ethanone, 1-(9H-pyrido[3,4-b]indol-1-yl)-; 1-acetyl-beta-carboline | C13H10N2O | 210.23 | CC(=O)C1=NC=CC2=C1NC3=CC=CC=C23 |
| TCMBANKIN016967 | Shinjulactone B | C19H22O7 | 362.37 | CC1C2CC(=O)OC3C2(C(=C(C1=O)O)C(C3)(C)C4C(=CC(=O)O4)C)CO | |
| TCMBANKIN017965 | ailanthinone | C25H34O9 | 478.5 g/mol | CCC(C)C(=O)OC1C2C(C(C3(C4C2(CO3)C(CC5C4(C(C(=O)C=C5C)O)C)OC1=O)O)O)C | |
| TCMBANKIN019700 | (3S,4R,6S)-6-[(3S,5R,9R,10R,13S,14S,17S)-3-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylheptane-2,3,4-triol | (3S,4R,6S)-6-[(3S,5R,9R,10R,13S,14S,17S)-3-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-heptane-2,3,4-triol | 476.82 | ||
| TCMBANKIN020005 | Dehydrocrebanine | 6,7-Dihydro-9,10-dimethoxy-7-methyl-5H-benzo(g)-1,3-benzodioxolo(6,5,4-de)quinoline; 77784-22-6; 5H-Benzo(g)-1,3-benzodioxolo(6,5,4-de)quinoline, 6,7-dihydro-9,10-dimethoxy-7-methyl-; dehydrocrebanine ; CCRIS 3812 | C20H19NO4 | 337.37 | CN1CCC2=CC3=C(C4=C5C=CC(=C(C5=CC1=C24)OC)OC)OCO3 |
| TCMBANKIN020566 | 947-59-1 | tricyclo[4.4.0.0~2,7~]dec-3-ene, 1,3-dimethyl-8-(1-methylethyl)-, (8R)-; 8-isopropyl-1,3-dimethyltricyclo[4.4.0.0~2,7~]dec-3-ene; InChI=1/C15H24/c1-9(2)11-7-8-15(4)12-6-5-10(3)14(15)13(11)12/h5,9,11-14H,6-8H2,1-4H3/t11-,12?,13?,14?,15?/m1/s; 4-Isopropyl-1,6-dimethyl-1,2,3,4,4a,5,8,8a-octahydro-1,5-cyclo-naphthalene | C15H24 | 204.35 | CC1=CCC2C3C1C2(CCC3C(C)C)C |
| TCMBANKIN021086 | krebiozen | Creatinine (NF); C4255_SIAL; Spectrum_000429; Spectrum2_000764; AI3-15321; D03600; 1-Methylhydantoin-2-imide; DivK1c_000351; Spectrum3_001717; KBioGR_002415; AIDS166904; Creatinine standard solution; KBio1_000351; C00791; C3613_SIGMA; 2-Imino-N-methylhydantoin; SPECTRUM1600300; BB_NC-0783; nchembio.78-comp6; 4H-Imidazol-4-one, 2-amino-1,5-dihydro-1-methyl-; NINDS_000351; KBio3_002554; InChI=1/C4H7N3O/c1-7-2-3(8)6-4(7)5/h2H2,1H3,(H2,5,6,8; NCGC00095762-01; 82016-55-5; C3488_SIGMA; 2-Amino-1,5-dihydro-1-methyl-4H-imidazol-4-one; 1-Methylglycocyamidine; 4H-Imidazol-4-one, 2-imino-1,5-dihydro-1-methyl-; KBio2_006045; CREATININE; EINECS 200-466-7; 2-amino-1-methyl-1,5-dihydro-4H-imidazol-4-one; KBioSS_000909; AIDS-166904; Spectrum4_001806; ZINC00967189; 2-Imino-1-methylimidazolidin-4-one; NSC13123; KBio2_003477; CHEBI:16737; 1-methyl-2-amino-imidazol-4-one; Creatinine (VAN) (8CI); NSC 13123; 2-imino-1-methyl-4-imidazolidinone; IDI1_000351; Spectrum5_000511; BSPBio_003334; 15231-31-9; Creatinine,heated; AO-840/40806907; SPBio_000808; SDCCGMLS-0066864.P001; 2-amino-1-methyl-5H-imidazol-4-one; 60-27-5; 45514-66-7; KBio2_000909 | C4H7N3O | 113.12 | CN1CC(=O)NC1=N |
| TCMBANKIN026070 | Shinjulactone K | 94451-22-6; Picrasane-1,16-dione, 12-(actyloxy)-2,12-dihydroxy-, (2.alpha.,11.alpha.,12.alpha.); AIDS-026415; Picrasane-1,16-dione, 12-(actyloxy)-2,12-dihydroxy-, (2alpha,11alpha,12alpha); shinjulactone k; AIDS026415 | C22H32O7 | 408.49 | CC1CC(C(=O)C2(C1CC3C4(C2C(C(C(C4CC(=O)O3)C)OC(=O)C)O)C)C)O |
| TCMBANKIN028904 | D-Friedoolean-14-en-3-one | (4aR,6aR,6aS,8aR,12aR,14aR,14bR)-4,4,6a,6a,8a,11,11,14b-octamethyl-2,4a,5,6,8,9,10,12,12a,13,14,14a-dodecahydro-1H-picen-3-one; ZINC04104836 | C30H48O | 424.7 | CC1(CCC2(CC=C3C4(CCC5C(C(=O)CCC5(C4CCC3(C2C1)C)C)(C)C)C)C)C |
| TCMBANKIN030259 | Neocembren A | C20H32 | 272.47 | CC1=CCCC(=CCC(CCC(=CCC1)C)C(=C)C)C | |
| TCMBANKIN032035 | (1R,8aS)-4-isopropyl-1,6-dimethyl-1,2,3,7,8,8a-hexahydronaphthalene | (1R,8aS)-1,6-dimethyl-4-propan-2-yl-1,2,3,7,8,8a-hexahydronaphthalene | C15H24 | 204.35 | |
| TCMBANKIN032096 | triterpenoidsaponin | triterpenoid saponin | 767.07 | CC1C2C(C(C(O1)OC3C(C(COC3OC(=O)C45CCC(CC4(C6=CCC7(C(C6(CC5)C)(CCC8C7(CC(C(C8(C)CO)OC9C(C(C(C(O9)CO)O)O)OC1C(C(C(C(O1)C(=O)CC(CC(=O)O2)(C)O)O)O)O)O)C)C)C)C)(C)C)O)O)O)OC1C(C(C(CO1)O)O)O | |
| TCMBANKIN032223 | Artelin | C15H18O5 | 278.3 | ||
| TCMBANKIN032960 | Shinjulactone C | C20H22O7 | 374.38 | CC1=CC(=O)C2(C3(C14CC5C6(C3C(=O)C2(C4(C6CC(=O)O5)C)O)CO)C)O | |
| TCMBANKIN033639 | 4,5-dihydrocanthin-6-one | C14H10N2O | 222.24 | ||
| TCMBANKIN034121 | 1-hydroxy-canthin-6-one | 1-hydroxycanthin-6-one | C14H8N2O2 | 236.23 | C1=CC=C2C(=C1)C3=C4N2C(=O)C=CC4=NC=C3O |
| TCMBANKIN034554 | 1,7,7-Trimethyl-2-vinylbicyclo[2.2.1]hept-2-ene | C12H18 | 162.27 | CC1(C2CCC1(C(=C2)C=C)C)C | |
| TCMBANKIN036829 | ursolic acid | ursolicacid; U6753_SIGMA; AIDS-039057; AKOS022168209; Urs-12-en-28-oic acid, 3beta-hydroxy- (8CI); 77-52-1; s2370; 3beta-Hydroxyurs-12-en-28-oic acid; SMR000445681; NSC4060; MLS000728569; Ursolic acid; TOS-BB-0966; 3beta-Hydroxy-12-ursen-28-ic acid; (1S,2R,4R,6aS,6bR,8aR,10S,12aR,12bR,14bR)-10-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,4a,5,6,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-octadecahydro-1H-picene-4-carboxylic acid; ursolic acid ; BSPBio_000018; NSC 167406; H719; 89797_FLUKA; EINECS 201-034-0; Prunol; BPBio1_000020; (1S,2R,4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-4a-carboxylic acid; AI3-03109; CHEBI:9908; ST056289; Ursolicacid; AC-8029; Urs-12-en-28-oic acid, 3-hydroxy-, (3beta)-; Ursolic acid (Malol); CCRIS 7123; BC216337; Urson; (3beta)-3-Hydroxyurs-12-en-28-oic acid; Prestwick3_000089; Malol; C08988; AKOS015965499; SCHEMBL1699371; MolPort-016-633-342; 209545-05-1; AS-13246; AIDS039057; NSC 4060 | C30H48O3 | 456.7 | CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)O)C)C)C2C1C)C)C(=O)[O-] |
| TCMBANKIN037277 | Oleanolic acid | Olean-12-en-28-oic acid, 3.beta.-hydroxy-; s2334; Caryophyllin; AIDS014809; Giganteumgenin C; SMR000445561; oleanolicacid; (3-beta)-3-Hydroxyolean-12-en-28-oic acid; AIDS-014809; Olean-12-en-28-oic acid, 3-hydroxy-, (3-beta)-; EINECS 208-081-6; NSC 114945; OLEANOLIC ACID; Olean-12-en-28-oic acid, 3-hydroxy-, (3beta)-; CCRIS 6493; AS-11663; SCHEMBL1699365; Virgaureagenin B; CHEBI:37659; MLS000697656; (4aS,5S,6aS,6bR,8R,8aR,10S,12aR,12bR,14bS)-10-Hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-octadecahydro-2H-picene-4a-carboxylic acid; AKOS022168208; O5504_SIGMA; MolPort-016-633-333; Oleanolic Acid; Olean-12-en-28-oic acid, 3-beta-hydroxy- (8CI); Oleanic acid; 3beta-Hydroxyolean-12-en-28-oic acid; 3-beta-Hydroxyolean-12-en-28-oic acid; ST057162; Olean-12-en-28-oic acid, 3beta-hydroxy- (8CI); NSC114945; Oleanolic Acid (Caryophyllin); Astrantiagenin C; Olean-12-en-28-oic acid, 3-hydroxy-, (3.beta.)-; 508-02-1; (4R,6aS,6bR,8aR,10S,12aR,12bR,14bR)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-3,4,4a,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1H-picene-4-carboxylic acid; (4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid; oleanolic acid | C30H48O3 | 457 | C1([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])C([H])=C([C@@]([H])(C([H])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])C2([H])[H])[C@@]2(C(=O)O[H])C([H])([H])C3([H])[H])[C@@]34C( [H])([H])[H])[C@@]4(C([H])([H])[H])C([H])([H])C5([H])[H])[C@@]5([H])C(C([H])([H])[H])(C([H])([H])[H])[C@@]1([H])O[H] |
| TCMBANKIN037298 | cis-Z-alpha-bisabolene epoxide | cis-Z-alpha.-Bisabolene epoxide; cis-Z-.alpha.-Bisabolene epoxide | C15H24O | 220.35 | C([H])([H])([H])\C(\C([H])([H])[H])=C([H])\C([H])([H])\C([H])=C(\[C@]1([H])C([H])([H])[C@]([H])(O2)[C@@]2(C([H])([H])[H])C([H])([H])C1([H])[H])/C([H])([H])[H] |
| TCMBANKIN037541 | alpha-Cubebene | α-cubebene; α- cubebene; 17699-14-8; alpha-cubebene; C09647 | C15H24 | 204.351 | C([H])([H])([H])[C@@]1([H])[C@@]2([C@]3([H])C(C([H])([H])[H])=C([H])C2([H])[H])[C@@]3([H])[C@]([H])(C([H])(C([H])([H])[H])C([H])([H])[H])C([H])([H])C1([H])[H] |
| TCMBANKIN037671 | bicyclogermacrene | Bicyclogermacrene; CHEMBL509566; CHEBI:63709; bicyclogermacrene | C15H24 | 204.351 | C1(C([H])([H])[H])(C([H])([H])[H])[C@]([H])(\C([H])=C(/C([H])([H])[H])\C([H])([H])C([H])([H])\C([H])=C(/C([H])([H])[H])\C([H])([H])C2([H])[H])[C@@]12[H] |
| TCMBANKIN037817 | γ-selinene | gamma-selinene; γ- Selinene; Eudesma-4(14),7(11)-diene - Substance | C15H24 | 204.35 | CC(=C1CCC2(CCCC(=C)C2C1)C)C |
| TCMBANKIN038435 | coniferin | 24-ethyl-5-bravery were steroids-3 beta alcohol; (2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[4-[(E)-3-hydroxyprop-1-enyl]-2-methoxyphenoxy]oxane-3,4,5-triol; 4-(3-hydroxyprop-1-en-1-yl)-2-methoxyphenyl beta-D-glucopyranoside; (2S,3R,4S,5S,6R)-2-[4-[(E)-3-hydroxyprop-1-enyl]-2-methoxy-phenoxy]-6-methylol-tetrahydropyran-3,4,5-triol; beta-D-Glucopyranoside, 4-(3-hydroxy-1-propenyl)-2-methoxyphenyl (VAN); (2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[4-[(E)-3-hydroxyprop-1-enyl]-2-methoxy-phenoxy]tetrahydropyran-3,4,5-triol; 531-29-3; ACon1_002032; (2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[4-[(E)-3-hydroxyprop-1-enyl]-2-methoxyphenoxy]tetrahydropyran-3,4,5-triol; (2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[4-[(E)-3-hydroxyprop-1-enyl]-2-methoxy-phenoxy]oxane-3,4,5-triol; MLS000563468; CHEBI:16220; Coniferin; Coniferyl alcohol beta-D-glucoside; C00761; MEGxp0_000873; SMR000470885 | C16H22O8 | 342.341 | c1(O[C@@]2([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]2([H])O[H])c(OC([H])([H])[H])c([H])c(\C([H])=C([H])\C([H])([H])O[H])c([H])c1[H] |
| TCMBANKIN039180 | Shinjudilactone | shinjudilactone | C20H24O7 | 376.4 | CC1C2CC(=O)OC3C24COC(=O)C1(C4C5(C(C3)C(=CC(=O)C5O)C)C)O |
| TCMBANKIN040391 | Germacrene D | C16142; (1E,6E,8S)-8-isopropyl-1-methyl-5-methylenecyclodeca-1,6-diene; (1E,6E,8S)-8-isopropyl-1-methyl-5-methylene-cyclodeca-1,6-diene; germacrene-d; (-)-Germacrene D; (1E,6E,8S)-1-methyl-5-methylidene-8-propan-2-yl-cyclodeca-1,6-diene; germacrene d; Germacrene- D; GermacreneD; (1E,6E,8S)-1-methyl-5-methylidene-8-propan-2-ylcyclodeca-1,6-diene; nchembio.2007.29-comp4 | C15H24 | 204.351 | C1([H])([H])C(=C([H])[H])\C([H])=C([H])\[C@]([H])(C([H])(C([H])([H])[H])C([H])([H])[H])C([H])([H])C([H])([H])\C(\C([H])([H])[H])=C([H])\C1([H])[H] |
| TCMBANKIN040702 | Globulol | viridiflorol | C15H26O | 222.366 | [C@@]1(C([H])([H])[H])(O[H])C([H])([H])C([H])([H])[C@@]([H])(C2(C([H])([H])[H])C([H])([H])[H])[C@]2([H])[C@]([H])([C@@]([H])(C([H])([H])[H])C([H])([H])C3([H])[H])[C@@]13[H] |
| TCMBANKIN045421 | canthin-6-one | NSC 103003; MEGxp0_000046; canthin-6-one; 6H-Indolo(3,2,1-de)(1,5)naphthyridin-6-one; NCIOpen2_007333; AIDS228088; ACon0_001416; AIDS-228088; C09098; NSC103003; 479-43-6; 6H-Indolo[3,2,1-de][1,5]naphthyridin-6-one; ZINC00898052 | C14H8N2O | 220.226 | c1([H])c([H])c(c2c(c(nc([H])c2[H])C([H])=C([H])C3=O)n34)c4c([H])c1[H] |
| TCMBANKIN049759 | 2-Hydroxychalcone | 513067_ALDRICH; 644-78-0(FREE ACID); (E)-3-(2-hydroxyphenyl)-1-phenyl-prop-2-en-1-one; trans-3-(O-Hydroxyphenyl)-1-phenyl-2-propen-1-one; AIDS017968; ARONIS019357; 42224-53-3; NSC640539; (E)-3-(2-hydroxyphenyl)-1-phenylprop-2-en-1-one; (2E)-3-(2-Hydroxyphenyl)-1-phenyl-2-propen-1-one; NSC 640539; (2E)-3-(2-hydroxyphenyl)-1-phenylprop-2-en-1-one; 644-78-0; NSC37432; AIDS-017968; NSC640539(FREE ACID); ST5039515; 3-(2-hydroxyphenyl)-1-phenylprop-2-en-1-one; 3-(2-hydroxyphenyl)-1-phenyl-prop-2-en-1-one; 2-Propen-1-one, 3-(2-hydroxyphenyl)-1-phenyl-; AI3-00855; .omega.-(Salicylidene)acetophenone; NSC170281; EINECS 211-422-1 | C15H12O2 | 224.25 | C1=CC=C(C=C1)C(=O)C=CC2=CC=CC=C2O |
| TCMBANKIN057969 | Azelex | 2,4 azelaic acid; NCGC00093565-03; Azelaic acid [USAN:INN]; Azelaic acid; NCGC00093565-04; KBio1_000532; 458317_ALDRICH; Acide azelaique [French]; Azelaic acid, technical grade; NSC 19493; SH-441; AI3-06299; Azelaic acid (USAN); Finacea; Emerox 1110; 1,9-Nonanedioic acid; 27825-99-6; NCGC00093565-02; KBio2_005573; Spectrum4_000401; A96150_ALDRICH; BRN 1101094; AZ1; Heptanedicarboxylic acid; DivK1c_000532; EU-0100051; ZK 62498; Lopac-246379; NCGC00093565-06; D03034; SPBio_001089; Acido azelaico [Spanish]; NINDS_000532; 123-99-9; Nonanedioic acid; 32733-99-6; LMFA01170054; AIDS002603; Polyazelaic anhydride; SMR000059164; BSPBio_001756; NCGC00014993-01; Acidum azelaicum [Latin]; Poly(azelaic anhydride); 4-02-00-02055 (Beilstein Handbook Reference); AIDS-002603; Lepargylic acid; AGN-191861; KBioGR_000662; C08261; LS-22779; SDCCGMLS-0066619.P001; KBio2_000437; KBioSS_000437; Skinoren; Spectrum2_000995; Azelaic polyanhydride; 246379_ALDRICH; 26776-28-3; 1,7-Heptanedicarboxylic acid; MLS000069659; Spectrum3_000278; Anchoic acid; NSC19493; Emerox 1144; Spectrum5_001304; Azelaic acid polyanhydride; EINECS 204-669-1; SPECTRUM1500648; KBio3_001256; KBio2_003005; Spectrum_000057; Lopac0_000051; Finacea (TN); IDI1_000532; ZK-62498; Nonanedioic acid, homopolymer; Finevin; Skinorem; Azelex (TN) | C9H16O4 | 188.22 g/mol | C(CCCC(=O)O)CCCC(=O)O |
| TCMBANKIN058213 | kaemferol;kampferol;kaempferol;campherol | TNP00039; nchembio.2007.28-comp30; Kaempherol; 5-18-05-00251 (Beilstein Handbook Reference); Prestwick2_001098; CHEBI:28499; Prestwick1_001098; CAS-520-18-3; BRN 0304401; Flavone, 3,4',5,7-tetrahydroxy-; ST030560; MEGxp0_001283; 4H-1-Benzopyran-4-one, 3,5,7-trihydroxy-2-(4-hydroxyphenyl)-5,7,4'-Trihydroxyflavonol; C.I. 75640; Swartziol; K0133_SIGMA; kaempferol oxoanion; NCGC00016480-01; 60010_FLUKA; EINECS 208-287-6; Pelargidenon; Nimbecetin; 3,5,7-trihydroxy-2-(4-hydroxyphenyl)-4-chromenone; NSC 407289; 3,4',5,7-Tetrahydroxyflavone; HSCI1_000027; Pelargidenolon 1497; NSC407289; Robigenin; C05903; CPD1F-90; Kampferol; NSC 656277; Prestwick0_001098; 3,5,7-trihydroxy-2-(4-hydroxyphenyl)chromen-4-one; Populnetin; Kampcetin; Prestwick3_001098; AIDS-001404; ZINC00137345; kaempferol ; 5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-3-olate; 3,4′,5,7-Tetrahydroxyflavone; Rhamnolutein; NCGC00016480-02; ACon1_001867; NSC656277; 3,4′,5,7-Tetrahydroxyflavone; BSPBio_001176; SPBio_003058; Oprea1_650954; 5,7,4'-Trihydroxyflavonol; 4H-1-Benzopyran-4-one,3,5,7-trihydroxy-2-(4-hydroxyphenyl)-5,7,4'-Trihydroxyflavonol; 4H-1-Benzopyran-4-one, 3,5,7-trihydroxy-2-(4-hydroxyphenyl)- (9CI); Campherol; 520-18-3; 3,5,7-TRIHYDROXY-2-(4-HYDROXYPHENYL)-4H-CHROMEN-4-ONE; S00111; Trifolitin; Kampherol; AI3-36096; 3,5,7-trihydroxy-2-(4-hydroxyphenyl)chromone; Indigo yellow; Pelargidenolon; AIDS001404; nchembio718-comp14; NCGC00091036-01; Flavone, 3,4',5,7-tetrahydroxy- (7CI,8CI); CHEBI:58573; Kaemferol; Kempferol; BPBio1_001294; 3,5,7-Trihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; Rhamnolutin; 3,5,7-triOH-Flavone; KMP; CCRIS 41; 4H-1-Benzopyran-4-one, 3,5,7-trihydroxy-2-(4-hydroxyphenyl)- | C15H10O6 | 286.24 g/mol | C1=CC(=CC=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O |
| TCMBANKIN058716 | β-selinene | ZINC8234293; (4aR,7R,8aS)-4a-methyl-1-methylidene-7-(prop-1-en-2-yl)decahydronaphthalene eudesma-4(14),11-diene; .beta.-Eudesmene; CHEBI:10443; YOVSPTNQHMDJAG-QLFBSQMISA-N; Eudesma-4(14),11-diene; (4aR,7R,8aS)-4a-methyl-1-methylidene-7-(prop-1-en-2-yl)decahydronaphthalene; (4aR,7R,8aS)-7-isopropenyl-4a-methyl-1-methylenedecahydronaphthalene; beta-selinene; CHEMBL2287242; beta-Selinene; eudesemene; 17066-67-0; beta-Eudesmene; BETA-SELINENE; beta-selinene ; (4aR,7R,8aS)-7-isopropenyl-4a-methyl-1-methylene-decalin; (4aR,7R,8aS)-7-isopropenyl-4a-methyl-1-methylenedecalin; beta-selinene ; β- Selinene; (+)-beta-Selinene; (3R,4aS,8aR)-8a-methyl-5-methylidene-3-prop-1-en-2-yl-1,2,3,4,4a,6,7,8-octahydronaphthalene; .beta.-Selinene; [4aR-(4aalpha,7alpha,8abeta)]-decahydro-4a-methyl-1-methylene-7-(1-methylethenyl)-naphthalene; 7-Isopropenyl-4a-methyl-1-methylenedecahydronaphthalene-, (4aR-(4a.alpha.,7.alpha.,8a.beta.))-; (4ar,7r,8as)-decahydro-4a-methyl-1-methylene-7-(1-methylethenyl)-naphthalene; AC1L9CQH; (+)-.beta.-Selinene; LMPR0103190014; C09723; Naphthalene, decahydro-4a-methyl-1-methylene-7-(1-methylethenyl)-, [4aR-(4a.alpha.,7.alpha.,8a.beta.)]-;eudesma-4(14),11-diene; Eudesma-4(14), 11-diene;b-selinene;Eudesma-4(14),11-diene;Selinene;(4aS,7S,8aR)-7-isopropenyl-4a-methyl-1-methylenedecalin;(4aS,7S,8aR)-7-isopropenyl-4a-methyl-1-methylene-decalin; 18423-23-9; Naphthalene, decahydro-4a-methyl-1-methylene-7-(1-methylethenyl)-, (4aR-(4aalpha,7alpha,8abeta))-; (3S,4aR,8aS)-8a-methyl-5-methylidene-3-prop-1-en-2-yl-1,2,3,4,4a,6,7,8-octahydronaphthalene | C15H24 | 204.35 g/mol | CC(=C)C1CCC2(CCCC(=C)C2C1)C |
| TCMBANKIN058851 | linalool | Spectrum5_000393; KBioGR_002294; KBio2_003260; KBio2_000692; (3R)-3,7-dimethylocta-1,6-dien-3-ol; W263516_ALDRICH; ZINC01529820;beta-linalool;NSC-3789; AK-50127; (+/-)-3,7-Dimethyl-1,6-octadien-3-ol; ACMC-209pf1; D0X5DC; Linalool Solution, 1000 mg/L, 1 ml (RM, ISO GUIDE 34); Linalool, primary pharmaceutical reference standard; CDOSHBSSFJOMGT-UHFFFAOYSA-N; AC1L1MRY; Howood Oil; 1,6-Octadien-3-ol, 3,7-dimethyl-, (3S)-; KSC377K8J; AC1Q1NVD; KB-179981; (+/-) LINALOOL; NCGC00259207-01; 3,6-dien-3-ol; AI3-00942; HSDB 645; (S)-Linalol; 2,7-Octadien-6-ol, 2,6-dimethyl-; 2,6-Dimethylocta-2,7-dien-6-ol; Linalool ex orange oil; (?)-3,7-Dimethyl-1,6-octadien-3-ol; DB-062552; I14-13929; FT-0614785; FCH1115719; Tox21_201658; 11024-20-7; BB_NC-00123; MolPort-001-783-101; LS-97796; 2,6-Dimethyl-2,7-octadien-6-ol; Linalool (natural); L0048; Linalool; BRN 1721488; 2,7-octadiene-6-ol; DSSTox_RID_77812; 3,7-Dimethyl-1,6-octadien-3-ol; BC207603; STL373777; AC1Q2BP3; FEMA No. 2635; ANW-37211; MCULE-2407576698; 3,6-octadien-3-ol; Natural Linalool; Linalool b; SCHEMBL20316; BBL027734; EINECS 204-811-2; LINALOOL (+); CU-01000013132-2; LINOLOOL (D); ST069326; dl-3,7-Dimethyl-3-hydroxy-1,6-octadiene; NSC 3789; CHEBI:17580; Linalool ex ho oil; Linalool, 97%; (.+/-.)-Linalool; allo-Ocimenol; GTPL2469; CCRIS 6557; ( -)-Linalool; BG00600803; NCGC00257060-01; C03985; EINECS 201-134-4; HMS2268E18; Tox21_303037; Phantol; (+-)-Linalool; SBB012353; SMR000112394; DTXSID7025502; (R)-3,7-Dimethyl-1,6-octadien-3-ol; DL -3,7-Dimethyl-3-hydroxy-1,6-octadiene; BB_NC-0123; NCGC00091688-04; (+/-)-3,7-Dimethyl-3-hydroxy-1,6-octadiene; CHEMBL25306; MLS002152908; WLN: 1Y1&U3XQ1&1U1 -,-; LINALYL ALCOHOL; Q-201306; 0-01-00-00462 (Beilstein Handbook Reference); SC-74998; CAS-78-70-6; (+/-)-linalool; LINALOOL EX BOIS DE ROSE; RTR-030706; NCGC00091688-02; Linalool, analytical standard; MFCD00008906; 1,6-OCTADIEN-3-OL, 3,7-DIMETHYL-, (-)-; Linalool, >=97%, FCC, FG; AC-551; Linolool; NSC3789; Linalool, certified reference material, TraceCERT(R); FEMA Number 2635; AKOS015901617; 3,7-Dimethyl-1, 6-octadien-3-ol; p-Linalool; Linalool ex bois de rose oil; FEMA 2635; DSSTox_CID_5502; .beta.-Linalool; EC 201-134-4; TR-030706; CTK2H7584; LS-1752; KS-00000WLW; 3,7-Dimethylocta-1,6-dien-3-ol; DSSTox_GSID_25502; WLN: 1U1XQ1&3UY1&1; 1,6-Octadien-3-ol, 3,7-dimethyl-; ( )-linalool; CCRIS 3726; Linanool; 78-70-6; NCGC00091688-03; Caswell No. 526A; AN-22986; 2,6-Dimethyl-2,7-octadiene-6-ol; (RS)-Linalool; RP21877; (1)-3,7-Dimethyl-1,6-octadien-3-ol; AN-15757; AC1Q1NVE; LINALOOL, (+-)-; NCGC00091688-01; Linalol; beta-Linalool; EINECS 245-083-6; 22564-99-4; Linalool, .beta.; 2,7-dien-6-ol; EPA Pesticide Chemical Code 128838; 1, 3,7-dimethyl-, (-)-; 3,7-dimethyl-octa-1,6-dien-3-ol;L-linalool;CJ-23937; Spectrum5_000393; LMPR0102010013; AKOS028109218; linalool ; Linalool; 1,6-Octadien-3-ol,3,7-dimethyl-, (3R)-; (R)-3,7-Dimethyl-1,6-octadien-3-ol; AC1L9E4Q; KBioGR_002294; (R)-3,7-dimethylocta-1,6-dien-3-ol; KBio2_003260; Epoxydihydrolinalool; KBio2_000692; (3R)-3,7-dimethylocta-1,6-dien-3-ol; ZINC1529820; Spectrum4_001777; C11388; linalool oxide; 126-91-0; 3U21E3V8I2; KBio3_002285; CCG-38497; CTK8F1408; KBio2_005828; KBioSS_000692; (-)-Linalool; EINECS 204-811-2; (-)-3,7-dimethyl-1,6-octadien-3-ol; LINALOOL (+); (3R)-Linalool; L-LINALOOL, REF. IND.-14<F128><144><F255>; CHEMBL235672; CHEBI:28; SpecPlus_000909; SCHEMBL891312; (-)-Linalool, analytical standard; UNII-3U21E3V8I2; KBio1_001949; J-005448; MolPort-003-666-060; NCGC00095658-01; FT-0772303; BSPBio_002785; SDCCGMLS-0066889.P001; UNII-D81QY6I88E component CDOSHBSSFJOMGT-JTQLQIEISA-N; L-Linalool; 1,6-OCTADIEN-3-OL, 3,7-DIMETHYL-, (-)-; L-Linalool, natural, >=95%, FG; SPBio_002007; Spectrum3_001173; 1,6-Octadien-3-ol, 3,7-dimethyl-, (3R)-; NCGC00095658-02; SPECTRUM1501212; SMP2_000331; (-)-Linalool, >=95.0% (sum of enantiomers, GC); Linalool, (-)-; 3R,7-dimethylocta-1,6-dien-3-ol; DivK1c_007005; (R)-linalool; (R)-(-)-3,7-Dimethyl-1,6-octadien-3-ol; DTXSID40872607; laevo-linalool; MFCD00135469; Spectrum2_001944; I14-45868; (3R)-3,7-dimethyl-1,6-octadien-3-ol; Spectrum_000212; (R)-(-)-Linalool | C10H18O | 154.25 g/mol | CC(=CCCC(C)(C=C)O)C |
| TCMBANKIN059175 | delta-elemene | delta-Elemene; g-elemene; cyclohexene,4-ethenyl-4-methyl-3-[1-methylethenyl]-1-[1-methylethyl]-; δ- elemene | C15H24 | 204.35 | CC(C)C1=CC(C(CC1)(C)C=C)C(=C)C |
| TCMBANKIN059316 | SMR000232320 | (5R,9R,10R,13S,14S,17S)-4,4,10,13,14-pentamethyl-17-[(2S,4R,5S)-4,5,6-trihydroxy-6-methyl-heptan-2-yl]-1,2,5,6,9,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-3-one; (5R,9R,10R,13S,14S,17S)-4,4,10,13,14-pentamethyl-17-[(2S,4R,5S)-4,5,6-trihydroxy-6-methylheptan-2-yl]-1,2,5,6,9,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-3-one; MLS000563510; (5R,9R,10R,13S,14S,17S)-4,4,10,13,14-pentamethyl-17-[(1S,3R,4S)-3,4,5-trihydroxy-1,5-dimethylhexyl]-1,2,5,6,9,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-3-one; (5R,9R,10R,13S,14S,17S)-4,4,10,13,14-pentamethyl-17-[(1S,3R,4S)-3,4,5-trihydroxy-1,5-dimethyl-hexyl]-1,2,5,6,9,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-3-one;piscidinol a | C30H50O4 | 474.7 g/mol | CC(CC(C(C(C)(C)O)O)O)C1CCC2(C1(CCC3C2=CCC4C3(CCC(=O)C4(C)C)C)C)C |
| TCMBANKIN059532 | (1R)-1, 7, 7-trimethyl-bicyclo[2.2.1]heptan-2-one | C10H16O | 152.23 g/mol | CC1(C2CCC1(C(=O)C2)C)C | |
| TCMBANKIN059571 | ZINC05224268 | C15H24 | 204.35 | CC1(CC2C1CCC3(C(O3)CCC2=C)C)C | |
| TCMBANKIN059614 | Amyrin | C30H50O | 426.72 | CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)O)C)C)C2C1)C)C)C | |
| TCMBANKIN059811 | guaiazulene | C15H18 | 198.3 g/mol | CC1=C2C=CC(=C2C=C(C=C1)C(C)C)C | |
| TCMBANKIN059907 | (+)-alpha-Curcumene | C15H22 | 202.33 g/mol | CC1=CC=C(C=C1)C(C)CCC=C(C)C | |
| TCMBANKIN059950 | Cadalin | C15H18 | 198.3 | CC1=CC2=C(C=CC(=C2C=C1)C)C(C)C | |
| TCMBANKIN059960 | (-)-g-cadinene | C15H24 | 204.35 g/mol | CC1=CC2C(CC1)C(=C)CCC2C(C)C | |
| TCMBANKIN059962 | cadinen;α-Cadinene;1,2,4a,5,6,8a-hexahydro-4,7-dimethyl-1-(1-methylethyl)naphthalene;1,2,4A,5,6,8A-hexahydro--4,7-dimethyl-(1-methylethyl)-naphthalene;muurolene;1,2,4a,5,6,8a- hexhydro- 4,7- dimethyl- 1-(1- methylethyl)-(1alpha 4a． alpha．,8a alpha． )- naphthalene;alpha cadinene;α-muurolene | C15H24 | 204.35 g/mol | CC1=CC2C(CC1)C(=CCC2C(C)C)C | |
| TCMBANKIN059964 | α-cadinol | C15H26O | 222.37g/mol | CC1=CC2C(CCC(C2CC1)(C)O)C(C)C | |
| TCMBANKIN059979 | calacorene | C15H20 | 200.32g/mol | CC1=CCC(C2=C1C=CC(=C2)C)C(C)C | |
| TCMBANKIN060014 | Germacrene D | C15H24 | 204.35 g/mol | CC1=CCCC(=C)C=CC(CC1)C(C)C | |
| TCMBANKIN060019 | Germacrene B | C15H24 | 204.35 | CC1=CCCC(=CCC(=C(C)C)CC1)C | |
| TCMBANKIN060264 | rutin | C27H30O16 | 610.5 g/mol | CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=C(OC4=CC(=CC(=C4C3=O)O)O)C5=CC(=C(C=C5)O)O)O)O)O)O)O)O | |
| TCMBANKIN060394 | Amarolide 11-acetate | C22H30O7 | 406.5 g/mol | CC1CC(C(=O)C2(C1CC3C4(C2C(C(=O)C(C4CC(=O)O3)C)OC(=O)C)C)C)O | |
| TCMBANKIN060443 | Bicyclo[4.4.0]dec-1-ene,2-isopropy-5-methyl-9-methylene- | C15H24 | 204.35 | CC1CCC(=C2C1CCC(=C)C2)C(C)C | |
| TCMBANKIN060459 | 1,4-diene juniper | C15H24 | CC1CCC(C2C1=CCC(=C2)C)C(C)C | ||
| TCMBANKIN060575 | alpha-gurjunene | C15H24 | 204.35 g/mol | CC1CCC2C(C2(C)C)C3=C(CCC13)C | |
| TCMBANKIN060593 | ()-Aromadendrene;(+)-aromadendrene | C15H24 | 204.35 | CC1CCC2C1C3C(C3(C)C)CCC2=C | |
| TCMBANKIN060679 | stigmasterol | C29H48O | 412.7 g/mol | CCC(C=CC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)C(C)C | |
| TCMBANKIN060687 | Hydroxysitosterol | C29H50O2 | 430.71 | CCC(CCC(C)C1CCC2C1(CCC3C2C(C=C4C3(CCC(C4)O)C)O)C)C(C)C | |
| TCMBANKIN060693 | Sitogluside | C35H60O6 | 576.85g/mol | CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C | |
| TCMBANKIN060694 | 24-Ethylcholest-4-en-3-one | C29H48O | 412.69 | CCC(CCC(C)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C)C(C)C | |
| TCMBANKIN061151 | triacontanol | C30H62O | 438.81 | CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO | |
| TCMBANKIN061291 | creatine | C4H9N3O2 | 131.13 g/mol | CN(CC(=O)O)C(=N)N | |
| TCMBANKIN061394 | Methyl caffeate | 2-Propenoic acid, 3-(3,4-dihydroxyphenyl)-, methyl ester, (2E)-; N79173B9HF; 3-(3,4-dihydroxyphenyl)acrylic acid methyl ester; (E)-3-(3,4-dihydroxyphenyl)acrylic acid methyl ester; BG01510488; STK523948; Caffeic acid methyl ester; Caffeic acid methyl; C10477; methyl (E)-3-(3,4-dihydroxyphenyl)-2-propenoate; AX8139367; CHEMBL17001; AKOS003263230; Methyl 1-(3'',4''-dihydroxyphenyl)propenate; ACM3843741; methyl 3-(3,4-dihydroxyphenyl)acrylate; caffeic acid methylester; Caffeic acid, methyl ester; J-502041; AK131257; ST5306988; 3-(3,4-dihydroxyphenyl)prop-2-enoic acid methyl ester; BG01510487; FCH5604426; AC1Q5YZ9; RL04585; ZX-AN022874; methyl (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate; ST094769; Methyl 1-(3',4'-Dihydroxyphenyl)Propenate; ZINC00058222; (E)-methyl-3-(3,4-dihydroxyphenyl)acrylate; 2-Propenoic acid, 3-(3,4-dihydroxyphenyl)-, methyl ester, (E)-; API0016257; AC1LENEX; KB-02534; Methyl 3,4-dihydroxycinnamate; SBB000325; AJ-09841; 3,4-dihydroxycinnamic acid methyl ester; (E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid methyl ester; AX8252180; AIDS-085228; SC-88492; TC-133588; METHYLCAFFEATE; 2-Propenoic acid, 3-(3,4-dihydroxyphenyl)-, methyl ester; (E)-3-(3,4-Dihydroxy-phenyl)-acrylic acid methyl ester; ZB002356; 3-(3,4-Dihydroxy-phenyl)-acrylic acid methyl ester; (E)-3-(3,4-Dihydroxyphenyl)propenoic Acid Methyl Ester; KB-255969; 4978AB; ST24031000; (E)-methyl 3-(3,4-dihydroxyphenyl)acrylate; BDBM50029209; methyl caffeate; BBV-44220535; 3843-74-1; R2609; CHEBI:6856; AIDS085228; OCNYGKNIVPVPPX-HWKANZROSA-N; AC1Q5YKG; (E)-3-(3,4-dihydroxyphenyl)-2-propenoic acid methyl ester; ALBB-024360; UNII-N79173B9HF; ZINC58222; Methylcaffeate; 67667-67-8; methyl 3-(3,4-dihydroxyphenyl)prop-2-enoate; MCULE-5269580490; C-1420; methyl (2E)-3-(3,4-dihydroxyphenyl)prop-2-enoate; MolPort-002-747-457; methyl (2E)-3-(3,4-dihydroxyphenyl)acrylate; (E)-Methyl3-(3,4-dihydroxyphenyl)acrylate; AK-88791; A4212/0179337; MFCD00210468; methyl (E)-3-[3,4-bis(oxidanyl)phenyl]prop-2-enoate; A824271 | C10H10O4 | 194.18 g/mol | COC(=O)C=CC1=CC(=C(C=C1)O)O |
| TCMBANKIN061528 | scopoletin | NINDS_000720; 7-hydroxy-6-methoxy-coumarin; NCGC00016349-05; 6-methoxy-7-hydroxycoumarin; 6-methoxy-7-oxidanyl-chromen-2-one; CHEBI:17488; SPBio_002884; HMS1571A05; RODXRVNMMDRFIK-UHFFFAOYSA-N; NCGC00016349-08; TR-029034; 5-18-03-00203 (Beilstein Handbook Reference); Acid, Gelseminic; 6-Methylesculetin; UNII-KLF1HS0SXJ; 7-hydroxy 6-methoxy coumarine; Scopoletin, >=99%; AB00443525; beta -methylesculetin; CS-5791; BRN 0156296; NCGC00094973-02; SR-01000841273-4; HMS2268G04; SCHEMBL147702; scopoletin ; Prestwick3_000962; CHEMBL71851; Escopoletin; Spectrum2_001207; HMS2098A05; NCGC00016349-07; NCGC00094973-03; Murrayetin; 7-Hydroxy-6-methoxy-2H-1-benzopyran-2-one; Bio-0208; NCGC00016349-02; Prestwick2_000962; ZB002243; BG01509594; NCGC00016349-03; BPBio1_001061; Scopoletin, analytical standard; AX8035441; 0B4B9FAA-686D-4977-AA08-65F8E4F1977C; BRD-K96163925-001-06-5; ZX-AN021883; FCH1115349; AC1NQX27; 7-hydroxy-6-methoxy-chromen-2-one; KBio3_002444; DTXSID0075368; 7-Hydroxy-5-methoxycoumarin; SC-90283; ST24045669; b-Methylaesculetin; KBioGR_001348; 7-Hydroxy-6-methoxy-2H-chromen-2-one #; Gelseminic acid; ZX-AFC000681; S0367; MLS002154074; 4CN-0905; 6-O-Methylesculetin; HMS502D22; KLF1HS0SXJ; MCULE-6077230919; MLS002472878; IDI1_000720; SPECTRUM1502242; Aesculetin 6-methyl ether; C-30831; MFCD00006872; Scopoletol; Buxuletin; AB0019688; CC-34387; Chrysotropic Acid; RTR-029034; ACon1_000143; CCRIS 3592; 6-Methoxyumbelliferone; LS-55217; NSC-405647; NSC 405647; 6-Methoxy-7-hydroxycoumarin; Esculetin-6-methyl ether; BDBM50156693; ZX-AT021192; AK111291; Scopoletin, United States Pharmacopeia (USP) Reference Standard; 7-Hydroxy-6-methoxy-2H-chromen-2-one; I14-14171; Prestwick1_000962; PubChem15777; MolPort-000-707-493; DivK1c_000720; A844290; AN-42608; NCGC00016349-04; ST056287; ZINC57733; BSPBio_002944; Chrysatropic acid; NCI60_003834; CAS-92-61-5; Acid, Chrysotropic; NSC405647; SR-01000841273; Prestwick0_000962; BSPBio_000963; KBio1_000720; FT-0631451; beta-Methylesculetin; Spectrum4_001054; SR-01000841273-3; AJ-09778; 7-Hydroxy-6-methoxycoumarin; W-3522; MEGxp0_001192; HY-N0342; NCGC00016349-06; Scopoletine; 7-hydroxy-6-methoxy-1-benzopyran-2-one; 006S872; OR22352; S-2000; NCGC00094973-01; EINECS 202-171-9; TNP00096; KS-00000YGS; Spectrum5_000654; Spectrum3_001532; TD8126; 2H-1-Benzopyran-2-one, 7-hydroxy-6-methoxy- (9CI); SPBio_000994; AKOS000277133; COUMARIN, 7-HYDROXY-6-METHOXY-; 2H-1-Benzopyran-2-one, 7-hydroxy-6-methoxy-; SMR000112541; BIDD:PXR0125; CCG-39140; Esculetin 6-methyl ether; D05QOR; 92-61-5; ALBB-023369; 7-hydroxy-6-methoxychromen-2-one; C01752; BIS1402; HMS1921N16; KB-249948; .beta.-Methylesculetin; NCGC00016349-01; Baogongteng B; 7-hydroxy-6-methoxy-chromen-2-one; KBio3_002444; NINDS_000720; 7-Hydroxy-5-methoxycoumarin; 7-hydroxy-6-methoxy-coumarin; Scopoletine; S2500_SIGMA; 7-hydroxy-6-methoxy-2H-chromen-2-one; CHEBI:17488; KBioGR_001348; SPBio_002884; Prestwick1_000962; NCGC00094973-01; 5-18-03-00203 (Beilstein Handbook Reference); EINECS 202-171-9; scopoletol; TNP00096; AIDS-014975; Gelseminic acid; DivK1c_000720; 6-O-Methylesculetin; Spectrum5_000654; Spectrum3_001532; 6-Methylesculetin; 2H-1-Benzopyran-2-one, 7-hydroxy-6-methoxy- (9CI); MEGxp0_001192; SPBio_000994; Scopoletin; 84792_FLUKA; IDI1_000720; COUMARIN, 7-HYDROXY-6-METHOXY-; 2H-1-Benzopyran-2-one, 7-hydroxy-6-methoxy-; ST056287; NCGC00094973-02; BRN 0156296; SPECTRUM1502242; Esculetin 6-methyl ether; BSPBio_002944; Chrysatropic acid; NCI60_003834; CAS-92-61-5; Prestwick3_000962; 7-hydroxy-6-methoxy-2-chromenone; Escopoletin; Spectrum2_001207; NCGC00094973-03; Murrayetin; 92-61-5; NSC405647; BSPBio_000963; NCGC00016349-02; KBio1_000720; 7-hydroxy-6-methoxychromen-2-one; Prestwick0_000962; 7-Hydroxy-6-methoxy-2H-1-benzopyran-2-one; C01752; ZINC00057733; AIDS014975; Prestwick2_000962; Spectrum4_001054; beta-Methylesculetin; ACon1_000143; BPBio1_001061; CCRIS 3592; 6-Methoxyumbelliferone; 7-Hydroxy-6-methoxycoumarin; .beta.-Methylesculetin; NCGC00016349-01; NSC 405647; 6-Methoxy-7-hydroxycoumarin; Esculetin-6-methyl ether; 6-methoxy-7-hydroxycoumarin; 7- hydroxy- 6-methoxy- coumarin; 6-methoxy-7-hydroxy coumarin; Scopoletol | C10H8O4 | 192.17 g/mol | COC1=C(C=C2C(=C1)C=CC(=O)O2)O |
| TCMBANKIN061900 | 1-methoxycanthin-6-one | 1-Methoxycanthinone; AIDS104956; 6H-Indolo(3,2,1-de)(1,5)naphthyridin-6-one, 1-methoxy-; AIDS-104956; 60755-86-4; 1-Methoxy-6H-indolo(3,2,1-de)(1,5)naphthyridin-6-one; 1-Methoxy-indolo[3,2,1-de][1,5]naphthyridin-6-one | C15H10N2O2 | 250.25 | COC1=CN=C2C=CC(=O)N3C2=C1C4=CC=CC=C43 |
| TCMBANKIN000020 | ailanthone | C20H24O7 | 376.4 g/mol | CC1=CC(=O)C(C2(C1CC3C45C2C(C(C(=C)C4CC(=O)O3)O)(OC5)O)C)O | |
| TCMBANKIN000204 | neoquassin | C22H30O6 | 390.5 g/mol | CC1C=C(C(=O)C2(C1CC3C4(C2C(=O)C(=C(C4CC(O3)O)C)OC)C)C)OC | |
| TCMBANKIN002264 | altissimacouniarin B | C21H26O6 | CC(=CCCC1(C(O1)COC2=C(C=C3C=CC(=O)OC3=C2OC)OC)C)C | ||
| TCMBANKIN005929 | 2,6-dimethoxy-p-cresol | C9H12O3 | 168.19 g/mol | CC1=CC(=C(C(=C1)OC)O)OC | |
| TCMBANKIN006056 | cabralealactone | C27H42O3 | 414.6 g/mol | CC1(C2CCC3(C(C2(CCC1=O)C)CCC4C3(CCC4C5(CCC(=O)O5)C)C)C)C | |
| TCMBANKIN007977 | Amarolide | AIDS-026413; Picrasane-1,12,16-trione, 2,11-dihydroxy-, (2.alpha.,11.alpha.)-; (2alpha,11alpha)-2,11-Dihydroxypicrasane-1,12,16-trione; 29913-86-8; amarolide; AIDS026413; Picrasane-1,12,16-trione, 2,11-dihydroxy-, (2alpha,11alpha)-; (2.alpha.,11.alpha.)-2,11-Dihydroxypicrasane-1,12,16-trione | C20H28O6 | 364.43 | CC1CC(C(=O)C2(C1CC3C4(C2C(C(=O)C(C4CC(=O)O3)C)O)C)C)O |
| TCMBANKIN010092 | betulafolienediolone | ||||
| TCMBANKIN010674 | shionone | (1R,4aS,4bS,6aS,8R,10aR,10bS,12aS)-1,4b,6a,8,10a,12a-hexamethyl-8-(4-methylpent-3-en-1-yl)hexadecahydrochrysen-2(1H)-one; UNII-BT0AMD31UB; Shionone; 10376-48-4; N2225; CHEBI:63459; BT0AMD31UB; Shionon; AKOS030573546; 2(1H)-Chrysenone,hexadecahydro-1,4b,6a,8,10a,12a-hexamethyl-8-(4-methyl-3-penten-1-yl)-,(1R,4aS,4bS,6aS,8R,10aR,10bS,12aS)-; D:A-Friedo-18,19-secolup-19-en-3-one; 376S484; C17966; ZINC6037228; AK608266; MolPort-020-005-764; FT-0697220; Ambap10376-48-4 | C30H50O | 426.72 | CC1C(=O)CCC2C1(CCC3C2(CCC4(C3(CCC(C4)(C)CCC=C(C)C)C)C)C)C |
| TCMBANKIN012407 | 24,25-dihydroxydammar-20-en-3-one | C30H50O3 | 458.7 g/mol | CC1(C2CCC3(C(C2(CCC1=O)C)CCC4C3(CCC4C(=C)CCC(C(C)(C)O)O)C)C)C | |
| TCMBANKIN013417 | altissimacouniarin G | C21H26O7 | CC(=CC1CC(C(O1)COC2=C(C=C3C=CC(=O)OC3=C2OC)OC)(C)O)C | ||
| TCMBANKIN014960 | altissimanins B | C30H50O3 | CC(CCC(C(C)(C)O)O)C1CCC2(C1(CCC3C2=CCC4C3(CCC(=O)C4(C)C)C)C)C | ||
| TCMBANKIN016778 | altissimanins D | C60H98O7 | CC(CC(C(C(C)(C)O)OC(=O)CCC1(C2CCC3(C(CCC3(C2CCC1C(=C)C)C)C4(CCC(O4)C(C)(C)O)C)C)C)O)C5CCC6(C5(CCC7C6=CCC8C7(CCC(=O)C8(C)C)C)C)C | ||
| TCMBANKIN017557 | altissimanins E | C60H98O7 | CC(CC(C(C(C)(C)O)O)OC(=O)CCC1(C2CCC3(C(CCC3(C2CCC1C(=C)C)C)C4(CCC(O4)C(C)(C)O)C)C)C)C5CCC6(C5(CCC7C6=CCC8C7(CCC(=O)C8(C)C)C)C)C | ||
| TCMBANKIN017677 | chasmanine | C25H41NO6 | 451.6 | CCN1CC2(CCC(C34C2C(C(C31)C5(CC(C6CC4C5C6O)OC)O)OC)OC)COC | |
| TCMBANKIN017965 | ailanthinone | C25H34O9 | 478.5 g/mol | CCC(C)C(=O)OC1C2C(C(C3(C4C2(CO3)C(CC5C4(C(C(=O)C=C5C)O)C)OC1=O)O)O)C | |
| TCMBANKIN019056 | 20(S)-hydroxy-25-melhoxydainmar-23-en-3-one | C13H9NO3S | C1=CSC(=C1)C=CC(=O)C2=CC=C(C=C2)[N+](=O)[O-] | ||
| TCMBANKIN019173 | bourjotinolone B | C30H48O3 | 456.7 g/mol | CC(CC(C(C(=C)C)O)O)C1CCC2(C1(CCC3C2=CCC4C3(CCC(=O)C4(C)C)C)C)C | |
| TCMBANKIN024140 | Quassin | Picrasa-2,12-diene-1,11,16-trione, 2,12-dimethoxy-; 1405-17-0; LMPR01060018; quassin; (3AS,6aR,7aS,8S,11aS,11bS,11cS)-1,3a,4,5,6a,7,7a,8,11,11a,11b,11c-dodecahydro-2,10-dimethoxy-3,8,11a,11c-tetramethyldibenzo(de,g)chromene-1,5,11-trione; C08778; 76-78-8; Quassine; 2,12-Dimethoxypicrasa-2,12-diene-1,11,16-trione; EINECS 200-985-9; AIDS026399; NSC 36342; AIDS-026399 | C22H28O6 | 388.45 | CC1C=C(C(=O)C2(C1CC3C4(C2C(=O)C(=C(C4CC(=O)O3)C)OC)C)C)OC |
| TCMBANKIN025680 | altissimanins A | ||||
| TCMBANKIN025946 | altissimacouniarin D | C21H26O5 | CC(=CCCC(=CCOC1=C(C=C2C=CC(=O)OC2=C1OC)OC)C)C | ||
| TCMBANKIN026070 | Shinjulactone K | 94451-22-6; Picrasane-1,16-dione, 12-(actyloxy)-2,12-dihydroxy-, (2.alpha.,11.alpha.,12.alpha.); AIDS-026415; Picrasane-1,16-dione, 12-(actyloxy)-2,12-dihydroxy-, (2alpha,11alpha,12alpha); shinjulactone k; AIDS026415 | C22H32O7 | 408.49 | CC1CC(C(=O)C2(C1CC3C4(C2C(C(C(C4CC(=O)O3)C)OC(=O)C)O)C)C)O |
| TCMBANKIN027522 | Cantleyine | methyl (6S,7R)-6-hydroxy-7-methyl-6,7-dihydro-5H-cyclopenta[d]pyridine-4-carboxylate; C09933; cantleyine; 30333-81-4; (6S,7R)-6-hydroxy-7-methyl-2-pyrindan-4-carboxylic acid methyl ester; (6S,7R)-6-hydroxy-7-methyl-6,7-dihydro-5H-cyclopenta[d]pyridine-4-carboxylic acid methyl ester | C11H13NO3 | 207.23 | CC1C(CC2=C(C=NC=C12)C(=O)OC)O |
| TCMBANKIN027860 | chaparrinone | C20H26O7 | 378.4 g/mol | CC1C2CC(=O)OC3C24COC(C1O)(C4C5(C(C3)C(=CC(=O)C5O)C)C)O | |
| TCMBANKIN029239 | 7α-hydroxy-sitosterol | ||||
| TCMBANKIN032018 | isofouquierone | C30H50O3 | 458.72 | CC1(C2CCC3(C(C2(CCC1=O)C)CCC4C3(CCC4C(C)(CC=CC(C)(C)O)O)C)C)C | |
| TCMBANKIN033014 | (20S,24R)-12β,25-dihydroxy-20,24-epoxydammarane-3-one | C30H50O4 | CC1(C2CCC3(C(C2(CCC1=O)C)CC(C4C3(CCC4C5(CCC(O5)C(C)(C)O)C)C)O)C)C | ||
| TCMBANKIN034458 | altissimanins C | ||||
| TCMBANKIN036948 | neoschaftoside | C26H28O14 | 564.5 g/mol | C1C(C(C(C(O1)C2=C3C(=C(C(=C2O)C4C(C(C(C(O4)CO)O)O)O)O)C(=O)C=C(O3)C5=CC=C(C=C5)O)O)O)O | |
| TCMBANKIN038176 | 2,3-Dimethoxy-9,10-dihydroxy-N-methyl-tetrahydroprotoberberine quaternary salt | C20H24NO4 | 342.409 | c1(OC([H])([H])[H])c([H])c(C([H])([H])C([H])([H])[N@@+](C([H])([H])[H])(C([H])([H])c(c(O[H])c(O[H])c([H])c2[H])c2C3([H])[H])[C@@]34[H])c4c([H])c1OC([H])([H])[H] | |
| TCMBANKIN038726 | Niloticin | CHEMBL460656 | 456.7 | ||
| TCMBANKIN039180 | Shinjudilactone | shinjudilactone | C20H24O7 | 376.4 | CC1C2CC(=O)OC3C24COC(=O)C1(C4C5(C(C3)C(=CC(=O)C5O)C)C)O |
| TCMBANKIN043657 | Ailantinol E | 388.4 g/mol | |||
| TCMBANKIN044098 | Ailantinol F | 362.4 g/mol | |||
| TCMBANKIN045421 | canthin-6-one | NSC 103003; MEGxp0_000046; canthin-6-one; 6H-Indolo(3,2,1-de)(1,5)naphthyridin-6-one; NCIOpen2_007333; AIDS228088; ACon0_001416; AIDS-228088; C09098; NSC103003; 479-43-6; 6H-Indolo[3,2,1-de][1,5]naphthyridin-6-one; ZINC00898052 | C14H8N2O | 220.226 | c1([H])c([H])c(c2c(c(nc([H])c2[H])C([H])=C([H])C3=O)n34)c4c([H])c1[H] |
| TCMBANKIN048898 | Ailantinol G | 480.5 g/mol | |||
| TCMBANKIN058972 | (23E)-3β,25-dihydroxytiriicalla-7,23-diene | C32H48O8 | CC(=O)OC(C)(C)C=CC(=O)C(C)(C1C(CC2(C1(CC(=O)C3(C2CC=C4C3CC(C(C4(C)C)O)O)C)C)C)O)O | ||
| TCMBANKIN059316 | SMR000232320 | (5R,9R,10R,13S,14S,17S)-4,4,10,13,14-pentamethyl-17-[(2S,4R,5S)-4,5,6-trihydroxy-6-methyl-heptan-2-yl]-1,2,5,6,9,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-3-one; (5R,9R,10R,13S,14S,17S)-4,4,10,13,14-pentamethyl-17-[(2S,4R,5S)-4,5,6-trihydroxy-6-methylheptan-2-yl]-1,2,5,6,9,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-3-one; MLS000563510; (5R,9R,10R,13S,14S,17S)-4,4,10,13,14-pentamethyl-17-[(1S,3R,4S)-3,4,5-trihydroxy-1,5-dimethylhexyl]-1,2,5,6,9,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-3-one; (5R,9R,10R,13S,14S,17S)-4,4,10,13,14-pentamethyl-17-[(1S,3R,4S)-3,4,5-trihydroxy-1,5-dimethyl-hexyl]-1,2,5,6,9,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-3-one;piscidinol a | C30H50O4 | 474.7 g/mol | CC(CC(C(C(C)(C)O)O)O)C1CCC2(C1(CCC3C2=CCC4C3(CCC(=O)C4(C)C)C)C)C |
| TCMBANKIN060394 | Amarolide 11-acetate | C22H30O7 | 406.5 g/mol | CC1CC(C(=O)C2(C1CC3C4(C2C(C(=O)C(C4CC(=O)O3)C)OC(=O)C)C)C)O | |
| TCMBANKIN060687 | Hydroxysitosterol | C29H50O2 | 430.71 | CCC(CCC(C)C1CCC2C1(CCC3C2C(C=C4C3(CCC(C4)O)C)O)C)C(C)C | |
| TCMBANKIN061900 | 1-methoxycanthin-6-one | 1-Methoxycanthinone; AIDS104956; 6H-Indolo(3,2,1-de)(1,5)naphthyridin-6-one, 1-methoxy-; AIDS-104956; 60755-86-4; 1-Methoxy-6H-indolo(3,2,1-de)(1,5)naphthyridin-6-one; 1-Methoxy-indolo[3,2,1-de][1,5]naphthyridin-6-one | C15H10N2O2 | 250.25 | COC1=CN=C2C=CC(=O)N3C2=C1C4=CC=CC=C43 |
| TCMBANKIN061901 | pinitol | Pinitol; ZINC3978754; ZINC242463987; ononitol; A800629; P2219; 60537-25-9; CTK5B1658; MLS002639102; Oprea1_249757; BG01510465; Quebrachitol; Pinitol, (+)-; SCHEMBL24537; NSC26254; Quebrachitol, (-)-; NSC-231332; Ononitol; 1-Methoxycyclohexane-2,3,4,5,6-pentaol; D-4-O-Methyl-myo-inositol; Inositol, L-chiro-; NSC128700; NSC-43336; L-chiro-Inositol, 2-O-methyl-; MolPort-023-220-422; NSC231332; 2-O-methyl-l-inositol; N934; MCULE-7951850879; Matezit; AKOS024283476; ST069274; AS-15082; NCGC00095666-01; SMR001548553; 6-methoxycyclohexane-1,2,3,4,5-pentaol; (3S,6S)-6-METHOXYCYCLOHEXANE-1,2,3,4,5-PENTOL; 2-0-methyl-chiro-inositol; VC30824; Pinite (inositol derivative); NSC-128700; NSC-131046; NSC-26254; Quebrachit; AC1L5KHM; CHEMBL171890; 4CN-0916; NSC131046; AC1Q79P1; (1r,2s,3s,4s,5s,6r)-6-methoxycyclohexane-1,2,3,4,5-pentaol; 6-methoxycyclohexane-1,2,3,4,5-pentol; NSC43336; epi-Inositol,6-O-methyl- (9CI); Sennit; l-quebrachitol | C7H14O6 | 194.18 g/mol | COC1C(C(C(C(C1O)O)O)O)O |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab